Clinical Trial: Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Phase 2 Study of Weekly Topotecan With Docetaxel for Recurrent Small Cell Lung Cancer
Brief Summary:
The purposes of this study are:
- To determine the overall response rate of patients treated with at least 2 cycles of this regimen.
- To determine the feasibility and toxicity of the combination of topotecan and docetaxel.
Detailed Summary:
Sponsor: Aultman Hospital
Current Primary Outcome: To determine the overall response rate of patients treated with at least two cycles of this regimen [ Time Frame: 3 years ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Aultman Hospital
Dates:
Date Received: April 17, 2006
Date Started: November 2004
Date Completion:
Last Updated: October 31, 2007
Last Verified: October 2007
